It’s a fundamental debate: is rosacea primarily a disorder of vascular etiology or is it a disorder of inflammation? It is a question that has management implications, and the answer is probably both!
Tomorrow afternoon, James Del Rosso, DO, will enlighten the audience with a discussion of this challenging disease, using this question as a springboard for the discussion of rosacea management. In his talk, Dr. Del Rosso will discuss the use of therapies such as oxymetazoline and ivermectin and will go one step further by explaining how and why they are effective in the treatment of rosacea.
This approach is sure to prove enlightening and make for an engaging discussion that will leave a lasting impression. Dr. Del Rosso will conclude the session by taking a look at the future of rosacea treatment, detailing new data on topical minocycline gel and foam formulations designed for treatment.